These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 14633256

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
    Manfroi S, Calisesi C, Fagiani P, Gabriele A, Lodi G, Nucci S, Pelliconi S, Righini L, Randi V.
    Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
    [Abstract] [Full Text] [Related]

  • 23. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
    Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM.
    Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
    [Abstract] [Full Text] [Related]

  • 24. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND.
    Methods Mol Biol; 2008 Feb; 444():185-201. PubMed ID: 18425481
    [Abstract] [Full Text] [Related]

  • 25. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K, Kjeldsen-Kragh J, Husby H, Akkök ÇA.
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [Abstract] [Full Text] [Related]

  • 26. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells.
    Lighten AD, Overton TG, Sepulveda W, Warwick RM, Fisk NM, Bennett PR.
    Am J Obstet Gynecol; 1995 Oct; 173(4):1182-5. PubMed ID: 7485316
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy.
    Moise KJ, Gandhi M, Boring NH, O'Shaughnessy R, Simpson LL, Wolfe HM, Baxter JK, Polzin W, Eddleman KA, Hassan SS, Skupski DW, Ryan G, Walker M, Lam G, Brown R, Skoll MA, Robinson C, Sheikh A, Bronsteen R, Plante LA, McLennan G, Chikova A, Paladino T.
    Obstet Gynecol; 2016 Dec; 128(6):1340-1346. PubMed ID: 27824757
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Fetal RhD genotyping by analysis of maternal blood. A case report.
    Tóth T, Papp C, Tóth-Pál E, Nagy B, Papp Z.
    J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
    [Abstract] [Full Text] [Related]

  • 33. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM.
    Transfus Clin Biol; 2006 Mar; 13(1-2):50-2. PubMed ID: 16563836
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
    Clausen FB, Barrett AN, Noninvasive Fetal RHD Genotyping EQA2017 Working Group.
    Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.